SGLT2 Inhibitors Tied to Lower Kidney Cancer Risk

• by Andrea Surnit

• June 9, 2026

Can Finerenone Alter Glomerular Disease Trajectory?

A prespecified exploratory analysis of the FIND-CKD clinical trial examined kidney function, albuminuria, and kidney failure outcomes in 903 patients with glomerular diseases.

• by Kathryn Wighton

• June 5, 2026

• 4 min

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.

• by Kathryn Wighton

• May 27, 2026

• 5 min

Oral HRS-7535 Lowered A1c in Trial

Nonpeptide oral agent requires no fasting administration.

• by Kathryn Wighton

• June 5, 2026

• 9 min